{
    "title": "Coherus BioSciences launches biosimilar version of AbbVie's blockbuster Humira",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12259087/Coherus-BioSciences-launches-biosimilar-version-AbbVies-blockbuster-Humira.html",
    "date": "2023-07-03",
    "keywords": [
        "drug",
        "coherus",
        "biosimilar",
        "humira",
        "market",
        "month",
        "carton",
        "insurance",
        "monday",
        "version",
        "discount",
        "blockbuster",
        "arthritis",
        "boehringer",
        "ingelheim",
        "sandoz",
        "organon",
        "yusimry",
        "list",
        "price",
        "company",
        "billionaire",
        "entrepreneur",
        "mark",
        "startup",
        "copycat",
        "medication",
        "leverage",
        "pharmacy",
        "benefit",
        "coverage",
        "behalf",
        "health",
        "year",
        "stabilize",
        "end",
        "drugmaker",
        "premarket",
        "trading",
        "reporting",
        "roy",
        "leroy",
        "leo",
        "bengaluru",
        "editing",
        "dasgupta",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}